nasdaq

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 02, 2025 16:42 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE)…

3 hours ago
XORTX Announces Receipt of Nasdaq NotificationRegarding Minimum Bid Price DeficiencyXORTX Announces Receipt of Nasdaq NotificationRegarding Minimum Bid Price Deficiency

XORTX Announces Receipt of Nasdaq NotificationRegarding Minimum Bid Price Deficiency

April 17, 2025 19:45 ET  | Source: XORTX Therapeutics Inc. CALGARY, Alberta, April 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics…

2 weeks ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 11, 2025 16:01 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio…

3 weeks ago
WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyWORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Hangzhou, China, April 11, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”),…

3 weeks ago
Polyrizon Receives Nasdaq Notification Regarding Minimum Bid RequirementsPolyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech…

3 weeks ago
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 07, 2025 17:00 ET  | Source: Anika Therapeutics Inc. BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics,…

4 weeks ago
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 04, 2025 16:05 ET  | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…

4 weeks ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…

4 weeks ago
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 04, 2025 16:30 ET  | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…

4 weeks ago
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 02, 2025 16:30 ET  | Source: Olema Oncology SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…

1 month ago